Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
Remyelination Therapy in Multiple Sclerosis.
Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions.
The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5.
Anthocyanin effects on microglia M1/M2 phenotype: Consequence on neuronal fractalkine expression.
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis.
[Targeted Therapy and Progressive Multifocal Leukoencephalopathy (PML): PML in the Era of Monoclonal Antibody Therapies].
Endocannabinoid signalling and the deteriorating brain.
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis.
Neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection.
A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase b1, is a risk factor for multiple sclerosis.
Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.
Correction: MRI Correlates of Disability in African-Americans with Multiple Sclerosis.
Substitutions mimicking deimination and phosphorylation of 18.5-kDa myelin basic protein exert local structural effects that subtly influence its global folding.
[Acute disseminated encephalomyelitis is an important differential diagnosis in the acutely affected child].
Lipopolysaccharide from Rhodobacter sphaeroides Attenuates Microglia-Mediated Inflammation and Phagocytosis and Directs Regulatory T Cell Response.
Remyelination in multiple sclerosis: realizing a long-standing challenge.
[Toxic demyelinating neuropathy and leukoencephalopathy in patients who take the slimming products Thermatrim ® and Pura Alegria ®].
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Pages
« first
‹ previous
…
563
564
565
566
567
568
569
570
571
…
next ›
last »